Contents

Current Drug Targets - Cardiovascular & Hematological Disorders, Volume 5 - Number 6

Editorial: Emerging Pharmacological Strategies for the Prevention of Atherosclerotic Disease Progression

, 5(6): 431 - 432

Paul Schoenhagen and Steven E. Nissen


DOI: 10.2174/156800605774962013




Animal Models of Atherosclerosis Progression: Current Concepts

, 5(6): 433 - 440

A. C. McMahon, L. Kritharides and H. C. Lowe


DOI: 10.2174/156800605774962031




HMG-CoA Reductase Inhibitors: Effects on Chronic Subacute Inflammation and Onset of Atherosclerosis Induced by Dietary Cholesterol

, 5(6): 441 - 453

R. Kleemann and T. Kooistra


DOI: 10.2174/156800605774962077




Cholesterol Absorption Blockade with Ezetimibe

, 5(6): 455 - 462

Peter P. Toth and Michael H. Davidson


DOI: 10.2174/156800605774962086




Inhibitors of Acyl-Coenzyme A: Cholesterol Acyltransferase

, 5(6): 463 - 469

Akira Miyazaki, Tomoko Kanome and Takuya Watanabe


DOI: 10.2174/156800605774962040




ApoA-I Milano/phospholipid Complexes Emerging Pharmacological Strategies and Medications for the Prevention of Atherosclerotic Plaque Progression

, 5(6): 471 - 479

Sanjay Kaul and Prediman K. Shah


DOI: 10.2174/156800605774962004




Increasing High-Density Lipoprotein Cholesterol Through Cholesteryl Ester Transfer Protein Inhibition: A Next Step in the Fight Against Cardiovascular Disease?

, 5(6): 481 - 488

W. A. Van der Steeg, K. El-Harchaoui, J. A. Kuivenhoven and J. J.P. Kastelein


DOI: 10.2174/156800605774961997




A Rationale for Combined Therapy with a Calcium Channel Blocker and a Statin: Evaluation of Basic and Clinical Evidence

, 5(6): 489 - 501

R. P. Mason


DOI: 10.2174/156800605774962112




Preventing Atherosclerosis with Angiotensin-Converting Enzyme Inhibitors: Emphasis on Diabetic Atherosclerosis

, 5(6): 503 - 512

T. J. Allen and K. A. Jandeleit-Dahm


DOI: 10.2174/156800605774962068




Peroxisome Proliferator-Activated Receptor ?? (PPAR??) and Atherosclerosis

, 5(6): 513 - 525

I. Gouni-Berthold and W. Krone


DOI: 10.2174/156800605774962022




Lipoprotein-associated Phospholipase A2: A Potential Therapeutic Target for Atherosclerosis

, 5(6): 527 - 532

A. Zalewski, C. Macphee and J. J. Nelson


DOI: 10.2174/156800605774962103




Liver X Receptors: Potential Novel Targets in Cardiovascular Diseases

, 5(6): 533 - 540

Dennis Bruemmer and Ronald E. Law


DOI: 10.2174/156800605774961988




Matrix Metalloproteinases: A Potential Therapeutic Target in Atherosclerosis

, 5(6): 541 - 548

Mustapha Rouis


DOI: 10.2174/156800605774961979




Endocannabinoid Receptor Antagonists and Other Emerging Pharmacological Strategies for Weight Reduction

, 5(6): 549 - 556

Kishore M. Gadde


DOI: 10.2174/156800605774962095




Non-invasive Atherosclerosis Imaging: Use to Assess Response to Novel or Combination Lipid Therapies

, 5(6): 557 - 564

Todd C. Villines and Allen J. Taylor


DOI: 10.2174/156800605774962059




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science